课题基金 / 基金详情

The Predictive Value of Pre-plus Disease in ROP

The Predictive Value of Pre-plus Disease in ROP
预加疾病对 ROP 的预测价值
批准号:
7110951
负责人:
DAVID K WALLACE
金额:
$26.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2009-07-31

项目摘要

项目成果

DAVID K WALLACE的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):该K23奖项将允许候选人获得必要的培训和技能,以开发和领导以患者为中心的儿科眼科研究项目,包括多中心临床试验。应聘者将学习研究设计、方案制定、拨款申请、项目管理、数据分析、统计方法、结果交流和医学伦理。为了实现这些目标,候选人将(1)在罗伊·贝克博士的直接指导下,在儿科眼病调查员小组进行的几项临床试验中工作,(2)获得公共卫生硕士学位,主修流行病学,辅修生物统计学,(3)在格雷厄姆·奎因博士的指导下完成早产儿视网膜病变(ROP)的研究项目,ROP是美国儿童失明的主要原因之一。拟议的研究项目将利用数字视网膜图像来检验我们的假设,即患有前加性疾病(轻度到中度异常血管扩张以及视网膜中央和后部血管弯曲)的眼睛更有可能发展为威胁视力的ROP。其具体目的是(1)调查预加试验是否预测进展为严重的ROP(临界性疾病),(2)确定预加试验是否增加了已建立的ROP描述符所提供的位置(区域)和严重程度(阶段)之外的预测价值,以及(3)研究预加试验疾病的自然病史。为了达到这些目标,ROP的2名蒙面专家将对150名婴儿的视频间接检眼镜产生的数字视网膜图像中血管扩张和弯曲的程度进行分级。关于进展到阈值的比例,PRE+的眼睛将与正常眼睛进行比较。如果PRE-PLUS能准确预测病情进展至临界值,则有重要的临床意义。这些措施包括提高识别可能从比平时更早的激光治疗中受益的高危婴儿的能力,对一些婴儿进行更有效的筛查方案,以及更准确地向父母提供关于疾病进展风险的咨询。
英文摘要
DESCRIPTION (provided by applicant): This K23 Award will allow the candidate to obtain the training and skills necessary to develop and lead patient-oriented research projects in pediatric ophthalmology, including multi-center clinical trials. The candidate will learn study design, protocol development, grant application, project management, data analysis, statistical methods, communication of results, and medical ethics. To achieve these objectives, the candidate will (1) work under the direct supervision of Dr. Roy Beck on several clinical trials conducted by the Pediatric Eye Disease Investigator Group, (2) obtain a masters degree in public health with a concentration in epidemiology and a minor in biostatistics, and (3) complete a research project with the guidance of Dr. Graham Quinn in retinopathy of prematurity (ROP), one of the leading causes of childhood blindness in the United States. The proposed research project will utilize digital retinal images to test our hypothesis that eyes with pre-plus disease (mild to moderately abnormal vascular dilation and tortuosity of central, posterior retinal blood vessels) are more likely to develop sight-threatening ROP. The specific aims are (1) to investigate whether pre-plus predicts progression to severe ROP (threshold disease), (2) to determine if pre-plus adds predictive value beyond that already provided by established ROP descriptors of location (zone) and severity (stage), and (3) to study the natural history of pre-plus disease. To address these aims, 2 masked experts in ROP will grade the degree of vascular dilation and tortuosity in digital retinal images generated from video indirect ophthalmoscopy in a cohort of 150 infants. Eyes with pre-plus will be compared to normal eyes in regard to the proportion that progress to threshold. There are important clinical implications if pre-plus accurately predicts progression to threshold. These include improved ability to identify high-risk infants who may benefit from earlier than usual laser treatment, more effective screening protocols for some infants, and more accurate counseling of parents regarding the risk of disease progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PEDIATRIC EYE DISEASE INVESTIGATOR GROUP: CHAIR'S OFFICE
  • 批准号:
    9211330
  • 项目类别:
  • 资助金额:
    $27.5万
  • 财政年份:
    2014
  • 负责人:
    DAVID K WALLACE
  • 依托单位:
PEDIATRIC EYE DISEASE INVESTIGATOR GROUP: CHAIR'S OFFICE
  • 批准号:
    8998949
  • 项目类别:
  • 资助金额:
    $27.5万
  • 财政年份:
    2014
  • 负责人:
    DAVID K WALLACE
  • 依托单位:
PEDIATRIC EYE DISEASE INVESTIGATOR GROUP: CHAIR'S OFFICE
  • 批准号:
    8474330
  • 项目类别:
  • 资助金额:
    $27.5万
  • 财政年份:
    2014
  • 负责人:
    DAVID K WALLACE
  • 依托单位:
The Predictive Value of Pre-plus Disease in ROP